Literature DB >> 19324106

The miR-200 family: central player for gain and loss of the epithelial phenotype.

Simone Spaderna, Thomas Brabletz, Oliver G Opitz.   

Abstract

Entities:  

Year:  2009        PMID： 19324106     DOI： 10.1053/j.gastro.2009.03.009

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  12 in total

1.  KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells.

Authors:  Baotong Zhang; Zhiqian Zhang; Siyuan Xia; Changsheng Xing; Xinpei Ci; Xin Li; Ranran Zhao; Sha Tian; Gui Ma; Zhengmao Zhu; Liya Fu; Jin-Tang Dong
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

2.  Transcription Factor Hepatocyte Nuclear Factor-1β (HNF-1β) Regulates MicroRNA-200 Expression through a Long Noncoding RNA.

Authors:  Sachin S Hajarnis; Vishal Patel; Karam Aboudehen; Massimo Attanasio; Patricia Cobo-Stark; Marco Pontoglio; Peter Igarashi
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

3.  miR-31 is a broad regulator of β1-integrin expression and function in cancer cells.

Authors:  Katarzyna Augoff; Mitali Das; Katarzyna Bialkowska; Brian McCue; Edward F Plow; Khalid Sossey-Alaoui
Journal:  Mol Cancer Res       Date:  2011-08-29       Impact factor: 5.852

Review 4.  Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis.

Authors:  Khalid Sossey-Alaoui
Journal:  Semin Cell Dev Biol       Date:  2012-10-29       Impact factor: 7.727

5.  The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion.

Authors:  Khalid Sossey-Alaoui; Katarzyna Bialkowska; Edward F Plow
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

6.  ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression.

Authors:  Young-Ho Ahn; Don L Gibbons; Deepavali Chakravarti; Chad J Creighton; Zain H Rizvi; Henry P Adams; Alexander Pertsemlidis; Philip A Gregory; Josephine A Wright; Gregory J Goodall; Elsa R Flores; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

7.  MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma.

Authors:  Li-Hsin Chen; Kun-Ling Tsai; Yi-Wei Chen; Cheng-Chia Yu; Kuo-Wei Chang; Shi-Hwa Chiou; Hung-Hai Ku; Pen-Yuan Chu; Ling-Ming Tseng; Pin-I Huang; Wen-Liang Lo
Journal:  J Oncol       Date:  2011-02-15       Impact factor: 4.375

8.  MicroRNAs involved in neoplastic transformation of liver cancer stem cells.

Authors:  Ren Li; Niansong Qian; Kaishan Tao; Nan You; Xinchuan Wang; Kefeng Dou
Journal:  J Exp Clin Cancer Res       Date:  2010-12-23

9.  Differences in the properties and mirna expression profiles between side populations from hepatic cancer cells and normal liver cells.

Authors:  Wei-hui Liu; Kai-shan Tao; Nan You; Zheng-cai Liu; Hong-tao Zhang; Ke-feng Dou
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

10.  The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200b.

Authors:  Khalid Sossey-Alaoui; Elzbieta Pluskota; Dorota Szpak; William P Schiemann; Edward F Plow
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.